Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0NDAEC
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
LMB-75
|
|||||
| Synonyms |
LMB75; LMB 75; anti-BCMA-disulfide-stabilized (ds)-Fv-PE24
Click to Show/Hide
|
|||||
| Organization |
National Institutes of Health
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 1 Indication(s)
Multiple myeloma [ICD11:2A83]
Clinical candidate
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Tumor necrosis factor receptor superfamily member 17 (TNFRSF17)
|
Antigen Info | ||||
| Payload Name |
Pseudomonas exotoxin PE24
|
Payload Info | ||||
| Therapeutic Target |
Eukaryotic elongation factor 2 (EEF2)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.